![cian diagnostics cian diagnostics](https://veterinarycytology.org/wp-content/uploads/2020/04/d4ccedcf-bebb-4602-b47e-67b28544650c-1-e1587834016788.jpg)
The Nanotrap® particle technology was developed with support from the National Institutes of Health, the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency, and the Commonwealth of Virginia. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. “We are very proud of this amazing set of organizations and look forward to identifying additional sites.”ĭetails with contact information for each Center of Excellence are listed below.Ĭeres Nanosciences is a privately held company, located in Prince William County, Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic and research products and workflows. “These sites encompass non-profit, university, public health, and commercial testing labs in eight states with a total population of more than 120 million people,” said Tara Jones-Roe, Vice President of Sales and Marketing for Ceres Nanosciences. Each site received the materials and on-site training from Ceres’ field applications team to implement an automated protocol, which increases capacity to 100 samples per day and improves turnaround times to less than eight hours. “A recent study by one of our university customers showed that 85% of the individual COVID-19 cases on campus were preceded by positive wastewater results.”Įach Center of Excellence was selected based on its ability to utilize the expanded capacity to extend services into underserved and underprivileged communities and to provide critical information to public health decision makers.
![cian diagnostics cian diagnostics](https://ciandx.com/wp-content/uploads/2021/03/Cian-Logo-square-300x253.png)
“Our customers have processed tens of thousands of samples from college dorms, K-12 schools, sleepaway camps, government facilities, and wastewater treatment plants,” said Ben Lepene, Chief Technology Officer at Ceres Nanosciences. Wastewater testing methods powered by the Nanotrap® Particles enable wastewater-based epidemiology at multiple levels in a community, including at the building level, at the neighborhoods sewershed level, and at the wastewater treatment plant level. These particles are compatible with a wide range of RNA extraction kits and detection methods, including reverse transcription-quantitative polymerase chain reaction (RT-qPCR), reverse transcription-droplet digital PCR (RT-ddPCR), and viral genome sequencing. Wastewater-based epidemiology can help communities monitor infection dynamics for SARS-CoV-2 and can serve as an early-warning system for the virus in a population, but widespread implementation has been stymied by lack of robust, high-throughput viral concentration methods.Ĭeres’ Nanotrap® Magnetic Virus Particles address this problem by enabling rapid viral concentration directly from raw sewage, significantly reducing the time and effort required to process wastewater samples. MANASSAS, Virginia – Novem– Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine new wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative.